Opus Genetics (IRD) Return on Invested Capital (2022 - 2024)

Opus Genetics (IRD) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q3 2024.

• Return on Invested Capital for Q3 2024 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Sep 2024 was 0.01% (down 1.0% YoY), and the FY2023 annual result was 0.0%, down 1.0% from the prior year.
• Return on Invested Capital eased to 0.01% in Q3 2024 per IRD's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.01% in Q3 2023 and troughed at 0.01% in Q3 2024.
• A 3-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 1 bps in 2023 and fell as far as 1 bps in 2023.
• A 3-year view of Return on Invested Capital shows it stood at 0.01% in 2022, then tumbled by 134 bps to 0.0% in 2023, then tumbled by 273 bps to 0.01% in 2024.
• Business Quant data shows IRD's Return on Invested Capital at 0.01% in Q3 2024, 0.0% in Q2 2024, and 0.0% in Q1 2024.